Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma
Abstract Glioblastoma multiforme (GBM) is recognized as the prevailing malignant and aggressive primary brain tumor, characterized by an exceedingly unfavorable prognosis. Cuproptosis, a recently identified form of programmed cell death, exhibits a strong association with cancer progression, therape...
Main Authors: | Lirui Dai, Peizhi Zhou, Liang Lyu, Shu Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-11727-z |
Similar Items
-
Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis
by: Longfei Yang, et al.
Published: (2022-09-01) -
A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas
by: HuaXin Zhu, et al.
Published: (2022-12-01) -
Cuproptosis in glioblastoma: unveiling a novel prognostic model and therapeutic potential
by: Zhigang Qin, et al.
Published: (2024-03-01) -
Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma
by: Zhen Zhang, et al.
Published: (2022-07-01) -
Elucidating Cuproptosis-Associated Genes in the Progression from Nash to HCC Using Bulk and Single-Cell RNA Sequencing Analyses and Experimental Validation
by: Zizuo Zhao, et al.
Published: (2023-09-01)